Light
Ritalin Paper Database
Light
Visual Abstract
Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study
How Methylphenidate (Ritalin) Affects Brain Activation Differently in ADHD vs. Healthy Children
October 18, 2024
author
Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD
journal
Proc Natl Acad Sci U S A
Date Published
1998 Nov 24
chart icon Visual
Original
A visual abstract on Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study
Study Summary
🔬
What They Studied
They studied how methylphenidate (Ritalin, Concerta) affects brain function during tasks requiring response inhibition in children with ADHD.
💡
What They Found
The study found that methylphenidate (Ritalin, Concerta) changes brain activity differently in children with ADHD compared to healthy children and improves response inhibition in ADHD children.
📚
What This Means
These findings align with existing evidence that methylphenidate (Ritalin, Concerta) affects brain function and can improve inhibitory control in children with ADHD, highlighting its distinct impact on the ADHD brain.
Study Summary
Study Overview
Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood developmental disorder that often continues into adulthood.

Methylphenidate, a medication used to treat ADHD, affects how certain brain areas work.

Research has found that children with ADHD display greater brain activity when trying to control their impulses compared to others.

Methylphenidate helped improve impulse control in ADHD children across different tasks.

This research shows that unique brain patterns are present in children, indicating that understanding ADHD may be different than previously thought.
Abstract: background
Functional MRI revealed differences between children with Attention Deficit Hyperactivity Disorder (ADHD) and healthy controls in their frontal–striatal function and its modulation by methylphenidate during response inhibition.
Cover photo for a study on "Effects of methylphenidate in ADHD: an fMRI study",
Impact of Dopaminergic Dysfunction
"Several lines of evidence suggest that ADHD is characterized by dysfunction in dopaminergic transmission in the frontal lobes and in striatal (basal ganglia) structures."
Novel Insights on Brain Function
"Our findings yield novel information about dopaminergic modulation of inhibitory control in healthy children."
Study Summary
Methods
Children with ADHD and healthy children were asked to complete two tasks that required them to respond quickly or stop their response. They performed these tasks twice, once with methylphenidate (Ritalin) and once without it. The researchers measured brain activity using functional MRI during these tasks.

The study focused on the differences in brain activation between the two groups. Specifically, they looked at the frontal and striatal regions of the brain, which are known to play a role in response inhibition, to see how the drug affected these areas.
Abstract: methods
Children performed two go/no-go tasks with and without drug. ADHD children had impaired inhibitory control on both tasks. Off-drug frontal–striatal activation during response inhibition differed between ADHD and healthy children: ADHD children had gr...more
Study Summary
Results
The effects of methylphenidate (Ritalin) on brain function were different for children with ADHD compared to healthy children. On one task, the drug improved response inhibition for both groups, but on the other task, it only helped children with ADHD. The drug increased brain activity in the frontal region equally for both groups during one of the tasks.

However, in the striatal region, it increased activation in children with ADHD but decreased it in healthy children. These findings indicate that ADHD is associated with unusual brain function in the frontal-striatal regions and that methylphenidate affects these areas differently depending on whether a child has ADHD.
Abstract: results
Drug effects differed between ADHD and healthy children: The drug improved response inhibition in both groups on one task and only in ADHD children on the other task. The drug modulated brain activation during response inhibition on only one task: It...more
Study Summary
Conclusions
The study concludes that children with ADHD show atypical function in the frontal and striatal brain regions, areas critical for controlling responses. Methylphenidate (Ritalin) helps improve these functions but affects brain activation differently in children with ADHD compared to healthy children.

These differences highlight the unique way ADHD affects the brain and how medication can help manage the symptoms by targeting specific brain regions. Understanding these effects can guide better treatment approaches for children with ADHD.
Abstract: conclusions
These results suggest that ADHD is characterized by atypical frontal–striatal function and that methylphenidate affects striatal activation differently in ADHD than in healthy children.
Key Takeaways for Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study
Background Information
Patient Guide
👨‍⚕️
Methylphenidate's Primary Uses
Primarily prescribed for treating ADHD in children older than six years and adults, methylphenidate helps manage symptoms effectively.
🧠
Mechanism of Action
Methylphenidate blocks norepinephrine and dopamine reuptake, increasing their concentrations and impacting brain function relevant to ADHD.
📉
Risks Associated with Long-term Use
Long-term methylphenidate use in children may result in decreased height, weight, and bone marrow density, necessitating regular monitoring.
Professional Guide
Expert Opinion: Effects of methylphenidate in ADHD: an fMRI study
Methylphenidate is recommended as the first-line pharmacologic treatment for preschool children due to its evidence-based efficacy and the limited studies supporting alternative medications.

It is considered particularly when behavioral interventions alone do not suffice.

Studies underscore combining medication with behavioral therapy for enhanced benefits in pre-adolescent children.
Evidence Summary
How Ritalin Affects Brain Activity
Taking Ritalin influences dopamine levels in the brain. This medication leads to changes in brain activity, which are explored in the research. The focus is on understanding how Ritalin affects users, particularly its impact on brain function.

The research connects the drug's influence on dopamine to shifts in brain activity. By examining these changes, scientists aim to understand the broader effects of Ritalin.

The study aims to understand how these changes impact people who use Ritalin for medical reasons, shedding light on the connection between the drug and brain activity.
Summary Card detailing the cognitive effects of methylphenidate on boys with AD/HD, highlighting improvements in spatial WM and visual search tasks.
Evidence Summary
Methylphenidate Enhances Cognitive Functions in ADHD
Methylphenidate, a common ADHD medication, shows promise in enhancing key cognitive functions like attention and mental performance. Research indicates it helps those with ADHD focus better and maintain sharper mental faculties.

Research-backed findings reveal how methylphenidate aids in improving attention, focus, and overall mental performance in individuals diagnosed with ADHD. This medication offers hope for better daily functioning.
Summary Card explaining how a once-a-day formulation of methylphenidate provides consistent and prolonged effectiveness for children with ADHD.
Evidence Summary
Methylphenidate in ADHD Treatment
Methylphenidate is often used to treat ADHD, helping improve focus and reduce hyperactivity and impulsiveness. While it can be effective, some common side effects include difficulty sleeping and loss of appetite.

The medication's ability to enhance focus and curb impulsive behavior makes it a frequent choice for managing ADHD symptoms. However, users should be aware of potential side effects like insomnia and decreased appetite.
A summary card describing a crossover trial of methylphenidate hydrochloride in children with hyperactivity and pervasive developmental disorders, detailing study methods and outcomes.